Skip to content

Creation of Arteriovenous Ante-brachial Fistula Under Axillary Block Versus Local Anesthesia : Impact on Early Complications

Creation of Arteriovenous Ante-brachial Fistula Under Axillary Block Versus Local Anesthesia : Impact on Early Complications

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02722096
Acronym
FAV ss ALR
Enrollment
78
Registered
2016-03-29
Start date
2014-03-31
Completion date
2018-03-15
Last updated
2025-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Failure, Chronic

Keywords

arteriovenous fistula, regional anesthesia, local anesthesia, early complication

Brief summary

Recommended by the KDOQI vascular access guidelines, antebrachial arteriovenous fistula is the best primary vascular access for hemodialysis in patients with end stage renal disease. The primary complications are common, of the order of 10-36 %, including lack of maturation and dominated by stenosis and thrombosis. Local anesthesia associated with sedation is a validated method of anesthesia for made arteriovenous fistula but does not cause the motor block and not blocking vasospasm, deleterious to the surgery. Multiple injections necessary to cover the operating zone expose patient to pain and to intravascular injection of local anesthetics. Regional anesthesia provides better conditions for realize more distal fistula. Sympathetic block provides arterial, venous vasodilation and decreases the incidence of vasospasm . It enables an increased flow rate at an early time fistula and faster maturation. However, studies included low numbers of patient or are non-randomized. They cannot concluded a significant difference in the complication rate of arteriovenous fistula at an early time depending on the type of anesthesia . This study aims to demonstrate that axillary block for surgical creation of arteriovenous fistula allows a reduction of complications at 6 weeks compared to local anesthesia

Interventions

DRUGAxillary block anesthesia with Ropivacaine and Lidocaine

Axillary brachial plexus block anesthesia with injection of Ropivacaine and Lidocaine will be performed by anesthetist 30 to 45 minutes before surgery

DRUGLocal anesthesia with Ropivacaine and Lidocaine

Local subcutaneous infiltration of Ropivacaine and Lidocaine will be performed by anesthetist at the beginning of surgery

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Chronic kidney disease stade 4 or 5 * First creation of arteriovenous fistula on the side of the surgery * written consent * Health care system adherent * No decision of juridical protection

Exclusion criteria

* Pregnancy or breast-feeding * Participation to an other research study that may interfere with this study * Brachial arterio-venous fistula creation (upper elbow crease) * Antecedent of homolateral arteriovenous fistula (controlateral fistula non excluded) * Other surgery on arteriovenous fistula (superficialisation procedure, refection…) * Contraindications to local anesthetics : Ropivacaine or Lidocaine allergy * Contraindication to regional anesthesia : homolateral axillary lymphadenectomy

Design outcomes

Primary

MeasureTime frameDescription
Rate of early complications related to arteriovenous fistula regardless of type6 weeks after surgeryEarly complications include stenosis of arteriovenous fistula, thrombosis, lack of maturation, high flow, clinical steal syndrome, arteriovenous fistula infection, arteriovenous fistula hemorrhage, necessity of radiologic ou surgical reintervention,

Secondary

MeasureTime frameDescription
Rate of stenosis of arteriovenous fistula6 weeks after surgerystenosis of arteriovenous fistula : resistance index \> 0.6, or peak velocity \> 300 cm/s and residual diameter \<3 mm
rate of thrombosis6 weeks after surgerythrombosis: resistance index = 1
incidence of abnormal arteriovenous fistula rate6 weeks after surgeryabnormal arteriovenous fistula rate : lack of maturation (blood flow \< 600 ml/min) or high flow (clinical heart failure, blood flow \> 1200 ml/min)
Rate of complications related to arteriovenous fistula regardless of type3 months after surgeryComplications included stenosis of arteriovenous fistula, thrombosis, lack of maturation, high flow, clinical steal syndrome, arteriovenous fistula infection, arteriovenous fistula hemorrhage, necessity of radiologic ou surgical reintervention.
incidence of arteriovenous fistula infection6 weeks after surgery
incidence of arteriovenous fistula hemorrhage6 weeks after surgeryarteriovenous fistula hemorrhage : spontaneous bleeding, post-puncture bleeding
necessity of radiologic ou surgical reintervention6 weeks after surgery
incidence of clinical steal syndrome6 weeks after surgeryclinical steal syndrome : trophic or neurological disorders

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026